Increase in Dopamine Turnover Occurs Early in Parkinson's Disease: Evidence from a New Modeling Approach to PET 18F-Fluorodopa Data
Open Access
- 1 February 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 22 (2) , 232-239
- https://doi.org/10.1097/00004647-200202000-00011
Abstract
An increase in dopamine turnover has been hypothesized to occur early in Parkinson's disease (PD) as a compensatory mechanism for dopaminergic neuronal loss. A new approach to the determination of dopamine turnover was developed using 4-hour-long 18F-fluorodopa (FD) positron emission tomography (PET) data. An effective dopamine turnover, an estimate of dopamine turnover, has been measured using its inverse, the effective dopamine distribution volume (EDV). This new method is based on a reversible tracer approach and determines the EDV using a graphical method. Six healthy subjects and 10 subjects with very early PD underwent a 4-hour-long FD scan. The EDV and the plasma uptake rate constant Ki, a marker of dopamine synthesis and storage, were compared according to their ability to separate the PD group from the healthy group. The EDV was the better discriminator (93.8% correct classification versus 81.3% for Ki). Effective dopamine distribution volume decreased by 65% in the PD group relative to the healthy group, whereas the decrease in Ki was 39%. These results show that changes in EDV are measurable with PET earlier than changes in the dopamine synthesis and storage rate, indicating that EDV is a sensitive marker for early PD and that a dopamine turnover increase likely serves as an early compensatory mechanism.Keywords
This publication has 22 references indexed in Scilit:
- 6-[18F]fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeysSynapse, 1998
- Fluorodopa Positron Emission Tomography with an Inhibitor of Catechol-O-Methyltransferase: Effect of the Plasma 3-O-Methyldopa Fraction on Data AnalysisJournal of Cerebral Blood Flow & Metabolism, 1996
- Links between 6-Fluorodopa and 6-Fluoro-3-O-methyldopa KineticsPublished by Elsevier ,1996
- Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal SubjectsJournal of Cerebral Blood Flow & Metabolism, 1993
- 6-[18F]fluoro-l-DOPA Metabolism in Living Human Brain: A Comparison of Six Analytical MethodsJournal of Cerebral Blood Flow & Metabolism, 1993
- Compensatory Mechanisms in Degenerative Neurologic DiseasesArchives of Neurology, 1991
- The Nigrostriatal Dopaminergic System Assessed In Vivo by Positron Emission Tomography in Healthy Volunteer Subjects and Patients With Parkinson's DiseaseArchives of Neurology, 1990
- 6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structuresJournal of Neuroscience Research, 1990
- THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSON'S DISEASE, STUDIED WITH PETBrain, 1990
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973